Treating Acute Covid-19 — Final Chapters Still Unwritten-Reference-Cited by-同舟云学术

Treating Acute Covid-19 — Final Chapters Still Unwritten

Published:2024-04-04 Issue:13 Volume:390 Page:1234-1236
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Gandhi Rajesh T.¹,Hirsch Martin¹

Affiliation:

1. From Massachusetts General Hospital and Harvard Medical School — both in Boston.

Publisher

Massachusetts Medical Society

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMe2402224

Reference10 articles.

1. COVID-19 Therapeutics for Nonhospitalized Patients—Updates and Future Directions

2. Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

3. Nirmatrelvir for vaccinated or unvaccinated adult outpatients with Covid-19.;Hammond J;N Engl J Med,2024

4. COVID-19 Treatment Guidelines Panel. Final coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health February 29 2024 (https://www.covid19treatmentguidelines.nih.gov/).

5. Infectious Diseases Society of America. IDSA guidelines on the treatment and management of patients with COVID-19. June 6 2023 (https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Molnupiravir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study);2024-09-09

2. Early use of oral antiviral drugs and the risk of post COVID-19 syndrome: A systematic review and network meta-analysis;Journal of Infection;2024-08

3. Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study);2024-07-01

4. Ivermectin as a Potential Addition to the Limited Anti-COVID-19 Arsenal: A Double-Blinded Clinical Trial;Jundishapur Journal of Health Sciences;2024-04-30